Taken together, these findings position S100A9 not only as a sensitive indicator of RCC presence and stage but also as a major link between DAMP-mediated inflammation and renal tumor biology, making it a promising target for diagnostic and therapeutic strategies in RCC [100] [Figure 3]. This evidence concerns the gene S100A9 and renal cell carcinoma.